AVANOS MEDICAL, INC.

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 TTM
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Net Income (Loss) Attributable to Parent $39.8m
$79.3m +99.25%
$57.5m -27.49%
($45.9m) -179.83%
($27.2m) +40.74%
$5.2m +119.12%
$50.5m +871.15%
($61.8m) -222.38%
($392.1m) -534.47%
($72.9m) +81.41%
Depreciation, Depletion and Amortization $65.2m $59.5m $33.5m $36.9m $42.9m $38.3m $47.7m $46.1m $45.5m $38.9m $39.5m
Depreciation $43.0m $19.0m $13.5m $16.9m $23.5m $21.6m $22.0m $19.2m $20.3m $19.7m $39.5m
Amortization of Intangible Assets $22.0m $21.0m $20.0m $20.0m $19.4m $16.7m $25.7m $24.3m $25.2m $19.2m
Amortization Cash Flow $16.7m $25.7m
Amortization Of Intangibles $16.7m $25.7m
Depreciation Amortization Depletion $47.7m $46.1m $45.5m $38.9m $39.5m
Deferred Income Tax Expense (Benefit) ($26.5m) ($9.5m) $3.7m ($15.0m) $11.6m $3.5m ($3.7m) ($8.1m) ($35.9m) ($7.8m)
Share-based Payment Arrangement, Noncash Expense $14.8m $12.6m $10.5m $10.5m $12.1m $13.2m $15.9m $15.8m $13.8m $12.6m $12.5m
Share-based Payment Arrangement, Expense $15.0m $13.0m $10.5m $12.1m $13.2m $15.9m $15.8m $13.8m $12.6m $12.5m
Gain (Loss) on Sale of Assets and Asset Impairment Charges ($1.1m) ($1.9m)
Goodwill and Intangible Asset Impairment $436.7m $77.0m
Goodwill, Impairment Loss $0 $0 $77.0m $513.7m
Impairment of Intangible Assets (Excluding Goodwill) $7.8m $7.8m $7.8m $0
Operating Lease, Impairment Loss $9.6m
Asset Impairment Charge $0 $0 $436.7m $77.0m $513.7m
Changes in operating assets and liabilities:
Change In Working Capital ($24.3m) ($18.0m) $35.0m $20.2m ($17.6m)
Increase (Decrease) in Accounts Receivable ($8.4m) $15.3m ($67.4m) $800k ($45.8m) $10.8m $24.7m ($39.0m) $6.6m ($30.9m) $5.5m
Change In Receivables ($24.7m) $39.0m ($6.6m) $30.9m $5.5m
Changes In Account Receivables ($24.7m) $39.0m ($6.6m) $30.9m $5.5m
Increase (Decrease) in Inventories ($41.0m) $16.8m $34.5m $21.3m $21.8m ($17.2m) $30.9m ($4.7m) ($39.0m) ($200k) $5.1m
Inventory Write-down $5.1m $5.6m $9.4m
Change In Inventory ($30.9m) $4.7m $39.0m $200k $5.1m
Change In Payables And Accrued Expense $28.3m ($42.1m) ($12.3m) ($12.3m) $4.9m
Change In Accrued Expense ($7.1m) ($27.7m) ($11.4m) ($12.9m) ($31.8m)
Other Operating Income (Expense), Net ($18.3m) ($20.1m) ($8.2m) ($21.1m) ($51.9m) ($22.8m) ($3.5m) ($13.3m) $3.9m $400k
Net Cash Provided by (Used in) Operating Activities $188.8m
$144.2m -23.62%
($145.6m) -200.97%
($74.5m) +48.83%
($2.5m) +96.64%
$87.3m +3592.00%
$90.9m +4.12%
$32.4m -64.36%
$100.7m +210.80%
$74.7m -25.82%
$36.7m -50.87%
Cash flows from investing activities:
Gain (Loss) on Disposition of Property Plant Equipment ($1.2m) ($9.3m) $9.2m
Capital Expenditure $29.1m $43.2m $49.1m $50.6m $20.2m $21.0m ($19.3m) ($17.8m) ($17.8m) ($31.6m) ($29.2m)
Payments to Acquire Investments $4.0m $0 $0
Payments to Acquire Businesses, Net of Cash Acquired $175.0m $0 $65.7m $57.5m $0 $0 $116.1m $49.6m $0 $28.0m ($34.0m)
Net Cash Provided by (Used in) Investing Activities ($200.9m) ($43.1m) $639.5m ($108.1m) ($24.2m) ($21.0m) ($135.4m) $21.6m ($27.5m) ($60.6m) ($59.2m)
Cash flows from financing activities:
Repayments of Long-term Debt $0 $0 ($34.4m)
Proceeds from Issuance of Long-term Debt $0 $0
Issuance Of Debt $400.0m $55.0m $20.0m $0 $0
Long Term Debt Issuance $400.0m $55.0m $20.0m $0 $0
Long Term Debt Payments ($296.6m) ($119.7m) ($53.6m) ($34.4m) ($34.4m)
Net Issuance Payments Of Debt $103.4m ($64.7m) ($33.6m) ($34.4m) ($9.4m)
Net Long Term Debt Issuance $103.4m ($64.7m) ($33.6m) ($34.4m) ($34.4m)
Repayment Of Debt ($296.6m) ($119.7m) ($53.6m) ($34.4m) ($34.4m)
Payments for Repurchase of Common Stock $900k $2.5m $900k $3.6m $900k $11.5m $45.5m $19.1m $12.8m $3.3m
Common Stock Payments ($45.5m) ($19.1m) ($12.8m) ($3.3m) ($2.4m)
Net Common Stock Issuance ($45.5m) ($19.1m) ($12.8m) ($3.3m) ($2.4m)
Repurchase Of Capital Stock ($45.5m) ($19.1m) ($12.8m) ($3.3m) ($2.4m)
Dividends paid $0
Proceeds from (Payments for) Other Financing Activities $0
Net Other Financing Charges ($2.9m) ($11.7m) ($3.8m) ($3.8m)
Net Cash Provided by (Used in) Financing Activities ($1.4m)
$2.2m +257.14%
($324.4m) -14845.45%
$1.5m +100.46%
($70.0m) -4766.67%
($55.3m) +21.00%
$56.7m +202.53%
($94.2m) -266.14%
($49.1m) +47.88%
($37.0m) +24.64%
($11.1m) +70.00%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect ($2.3m) $2.7m $164.8m ($179.2m) ($93.8m) $7.0m $9.2m ($40.0m) $20.0m ($17.9m) $63.4m
Beginning Cash Position $118.5m $127.7m $87.7m $107.7m $97.0m
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $384.5m $205.3m $111.5m $118.5m $127.7m $87.7m $107.7m $89.8m $63.4m
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents ($2.3m) $2.7m ($4.7m) $1.9m $2.9m ($4.0m) ($3.0m) $200k ($4.1m) $5.0m $2.2m
Effect Of Exchange Rate Changes ($3.0m) $200k ($4.1m) $5.0m $2.2m
Additional Supplementary Disclosures
Additional Supplementary Disclosures
Proceeds from Stock Options Exercised $4.7m $17.1m $5.3m $3.4m $6.2m $1.7m $1.3m $1.1m $700k
Supplemental disclosure of cash flow information:
Interest Paid, Excluding Capitalized Interest, Operating Activities $29.9m $28.7m $20.6m $16.7m $16.8m $3.0m $8.1m $14.7m $11.5m $6.5m
Income Taxes Paid, Net $29.1m $21.4m $96.6m $8.4m $0 ($45.0m) ($2.9m) $23.6m $3.3m $14.1m
Additional Financial Items
Gain (Loss) on Disposition of Assets ($3.7m) ($3.3m) ($1.5m) ($600k) ($2.2m) ($100k)
Gain (Loss) on Disposition of Business ($70.8m) $0 $0
Gain (Loss) on Termination of Lease $6.9m
Goodwill $1.0b $764.7m $783.6m $800.9m $802.5m $801.6m $819.4m $796.1m $455.6m $394.9m $513.7m
Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent ($32.1m) ($8.5m) ($45.9m) ($27.2m) ($9.9m) ($386.3m) ($72.9m)
Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent $111.4m $66.0m $0 $0 ($51.9m) ($5.8m) $0
Income Tax Expense (Benefit) $15.5m ($40.1m) ($9.6m) ($18.1m) ($33.3m) $600k $14.7m $2.0m ($17.0m) $6.7m
Interest Expense Nonoperating $12.2m $7.8m
Investment Income, Interest $600k $2.5m $7.8m $6.7m $1.2m $200k $1.2m $2.9m $5.1m $3.2m
Cash Flow From Continuing Financing Activities $56.7m ($94.2m) ($49.1m) ($37.0m) ($11.1m)
Cash Flow From Continuing Investing Activities ($135.4m) $21.6m ($27.5m) ($60.6m) ($59.2m)
Change In Account Payable $35.4m ($14.4m) ($900k) $600k $4.9m
Change In Cash Supplemental As Reported $9.2m ($40.0m) $20.0m ($17.9m)
Change In Payable $35.4m ($14.4m) ($900k) $600k $4.9m
Change In Prepaid Assets $3.0m ($19.6m) $14.9m $1.4m ($1.3m)
Changes In Cash $12.2m ($40.2m) $24.1m ($22.9m) ($33.6m)
End Cash Position $127.7m $87.7m $107.7m $89.8m $63.4m
Financing Cash Flow $56.7m
($94.2m) -266.14%
($49.1m) +47.88%
($37.0m) +24.64%
($11.1m) +70.00%
Free Cash Flow $71.6m $14.6m $82.9m $43.1m $7.5m
Gain Loss On Sale Of Business $0 $70.8m $0 $0 $0
Investing Cash Flow ($135.4m) $21.6m ($27.5m) ($60.6m) ($59.2m)
Net Business Purchase And Sale ($116.1m) $39.4m ($9.7m) ($33.0m) ($34.0m)
Operating Gains Losses $1.1m $72.7m $1.2m $9.3m $9.2m
Proceeds From Stock Option Exercised $1.7m $1.3m $1.1m $700k $700k
Purchase Of Business ($116.1m) ($49.6m) ($11.8m) ($33.0m) ($34.0m)
Sale Of Business $0 $89.0m $2.1m $0 $0
Stock Based Compensation $15.9m $15.8m $13.8m $12.6m $12.5m

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.